Over the past year, GOVX insiders bought $5,498 of stock on the open market and sold none.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | David A Dodd | President, Ceo | 1,466 | 0 | 1,466 | 43.5% | 01 Apr, 2025 |
| 2 | John N Jr Spencer | Director | 856 | 0 | 856 | 25.4% | 20 Oct, 2025 |
| 3 | Mark Reynolds | Cfo | 561 | 0 | 561 | 16.6% | 31 Mar, 2025 |
| 4 | John W. Sharkey | Vp, Business Development | 248 | 0 | 248 | 7.4% | 10 Apr, 2025 |
| 5 | Kelly T. Jr. Mckee | Chief Medical Officer | 140 | 0 | 140 | 4.1% | 08 Aug, 2025 |
| 6 | Randal D Chase | Director | 98 | 0 | 98 | 2.9% | 23 Sep, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 17 Jun, 2026 | David A Dodd | President, Ceo | Acquired A | 29,300 | $0.00 | $0 | 29,300 | Direct |
| 17 Jun, 2026 | Robert T Mcnally | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Jun, 2026 | Mark J Newman | Chief Scientific Officer | Acquired A | 17,600 | $0.00 | $0 | 17,600 | Direct |
| 17 Jun, 2026 | John W. Sharkey | Vp, Business Development | Acquired A | 17,600 | $0.00 | $0 | 17,600 | Direct |
| 17 Jun, 2026 | Randal D Chase | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Jun, 2026 | Kelly T. Jr. Mckee | Chief Medical Officer | Acquired A | 17,600 | $0.00 | $0 | 17,600 | Direct |
| 17 Jun, 2026 | Dean G Kollintzas | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Jun, 2026 | Mark Reynolds | Cfo | Acquired A | 17,600 | $0.00 | $0 | 17,600 | Direct |
| 17 Jun, 2026 | John N Jr Spencer | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Jun, 2026 | Jayne Morgan | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Jun, 2026 | Nicole Lemerond | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 17 Oct, 2025 | John N Jr Spencer | Director | Acquired P | 10,000 | $13.75 | $137.45K | 856 | Direct |
| 07 Aug, 2025 | Kelly T. Jr. Mckee | Chief Medical Officer | Acquired P | 1,107 | $16.75 | $18.54K | 140 | Direct |
| 05 Jun, 2025 | Robert T Mcnally | Director | Acquired A | 10,000 | $0.00 | $0 | 400 | Direct |
| 05 Jun, 2025 | Mark J Newman | Chief Scientific Officer | Acquired A | 70,000 | $0.00 | $0 | 2,800 | Direct |
| 05 Jun, 2025 | Mark Reynolds | Cfo | Acquired A | 70,000 | $0.00 | $0 | 2,800 | Direct |
| 05 Jun, 2025 | Jayne Morgan | Director | Acquired A | 10,000 | $0.00 | $0 | 400 | Direct |
| 05 Jun, 2025 | Nicole Lemerond | Director | Acquired A | 10,000 | $0.00 | $0 | 400 | Direct |
| 05 Jun, 2025 | John N Jr Spencer | Director | Acquired A | 10,000 | $0.00 | $0 | 400 | Direct |
| 05 Jun, 2025 | John W. Sharkey | Vp, Business Development | Acquired A | 70,000 | $0.00 | $0 | 2,800 | Direct |